1. Home
  2. TRAK vs TNYA Comparison

TRAK vs TNYA Comparison

Compare TRAK & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$8.30

Market Cap

157.2M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.69

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRAK
TNYA
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
168.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
TRAK
TNYA
Price
$8.30
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
58.0K
2.0M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
0.90%
N/A
EPS Growth
20.69
54.96
EPS
0.28
N/A
Revenue
$21,007,076.00
N/A
Revenue This Year
$6.61
N/A
Revenue Next Year
$10.04
N/A
P/E Ratio
$28.39
N/A
Revenue Growth
4.84
N/A
52 Week Low
$6.94
$0.53
52 Week High
$18.05
$2.35

Technical Indicators

Market Signals
Indicator
TRAK
TNYA
Relative Strength Index (RSI) 42.34 41.07
Support Level $7.94 $0.65
Resistance Level $9.06 $0.81
Average True Range (ATR) 0.42 0.03
MACD -0.01 -0.00
Stochastic Oscillator 49.23 26.13

Price Performance

Historical Comparison
TRAK
TNYA

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: